Table 1.
Mouse strain | ΔmglA deposition dose (CFU/lung) | U112 challenge deposition dose (CFU/lung)a | Survival at 96 hoursd |
---|---|---|---|
C57BL/6 | 2 × 103 2 × 103 |
8 × 104 2 × 103 |
0/4 0/4 |
BALB/c | 1 × 105 3 @ 1 × 105b |
6 × 102 35c |
0/4 0/4 |
Except where noted, U112 challenges were performed 6-8 weeks after ΔmglA infections.
Intervals between three successive ΔmglA infections were 8 and 4 weeks.
U112 challenge was performed 4 weeks after third ΔmglA infection.
Mice were observed for death or illness, and euthanized when moribund. Unvaccinated C57BL/6 mice challenged with 8 × 104 CFU/lung U112 and BALB/c mice challenged with 6 × 102 CFU/lung U112 had 100% mortality at 96 hours (n=4 per group).